Literature DB >> 24448236

Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer.

Andreas Göhrig1, Katharina M Detjen, Georg Hilfenhaus, Jan L Körner, Martina Welzel, Ruza Arsenic, Rosa Schmuck, Marcus Bahra, Jane Y Wu, Bertram Wiedenmann, Christian Fischer.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) metastasizes by neural, vascular, and local invasion routes, which limit patient survival. In nerves and vessels, SLIT2 and its ROBO receptors constitute repellent guidance cues that also direct epithelial branching. Thus, the SLIT2-ROBO system may represent a key pinch point to regulate PDAC spread. In this study, we examined the hypothesis that escaping from repellent SLIT2-ROBO signaling is essential to enable PDAC cells to appropriate their local stromal infrastructure for dissemination. Through immunohistochemical analysis, we detected SLIT2 receptors ROBO1 and ROBO4 on epithelia, nerves, and vessels in healthy pancreas and PDAC specimens, respectively. SLIT2 mRNA expression was reduced in PDAC compared with nontransformed pancreatic tissues and cell lines, suggesting a reduction in SLIT2-ROBO pathway activity in PDAC. In support of this interpretation, restoring the SLIT2 expression in SLIT2-deficient PDAC cells inhibited their bidirectional chemoattraction with neural cells, and more specifically, impaired unidirectional PDAC cell navigation along outgrowing neurites in models of neural invasion. Restoring autocrine/paracrine SLIT2 signaling was also sufficient to inhibit the directed motility of PDAC cells, but not their random movement. Conversely, RNA interference-mediated silencing of ROBO1 stimulated the motility of SLIT2-competent PDAC cells. Furthermore, culture supernatants from SLIT2-competent PDAC cells impaired migration of endothelial cells (human umbilical vein endothelial cells), whereas an N-terminal SLIT2 cleavage fragment stimulated such migration. In vivo investigations of pancreatic tumors with restored SLIT2 expression demonstrated reduced invasion, metastasis, and vascularization, with opposing effects produced by ROBO1 silencing in tumor cells or sequestration of endogenous SLIT2. Analysis of clinical specimens of PDAC showed that those with low SLIT2 mRNA expression exhibited a higher incidence and a higher fraction of tumor-infiltrated lymph nodes. Taken together, our findings argue that disrupting SLIT2-ROBO signaling in PDAC may enhance metastasis and predispose PDAC cells to neural invasion. ©2014 AACR

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24448236     DOI: 10.1158/0008-5472.CAN-13-1012

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

Review 1.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

Review 2.  How Schwann cells facilitate cancer progression in nerves.

Authors:  Sylvie Deborde; Richard J Wong
Journal:  Cell Mol Life Sci       Date:  2017-06-19       Impact factor: 9.261

3.  A conserved major facilitator superfamily member orchestrates a subset of O-glycosylation to aid macrophage tissue invasion.

Authors:  Katarina Valoskova; Julia Biebl; Marko Roblek; Shamsi Emtenani; Attila Gyoergy; Michaela Misova; Aparna Ratheesh; Patricia Reis-Rodrigues; Kateryna Shkarina; Ida Signe Bohse Larsen; Sergey Y Vakhrushev; Henrik Clausen; Daria E Siekhaus
Journal:  Elife       Date:  2019-03-26       Impact factor: 8.140

Review 4.  Neural plasticity in pancreatitis and pancreatic cancer.

Authors:  Ihsan Ekin Demir; Helmut Friess; Güralp O Ceyhan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-10-13       Impact factor: 46.802

Review 5.  Signaling in the microenvironment of pancreatic cancer: Transmitting along the nerve.

Authors:  Noelle Jurcak; Lei Zheng
Journal:  Pharmacol Ther       Date:  2019-04-29       Impact factor: 12.310

6.  LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancer.

Authors:  Tiansuo Zhao; He Ren; Jing Li; Jing Chen; Huan Zhang; Wen Xin; Yan Sun; Lei Sun; Yongwei Yang; Junwei Sun; Xiuchao Wang; Song Gao; Chongbiao Huang; Huafeng Zhang; Shengyu Yang; Jihui Hao
Journal:  Cancer Res       Date:  2014-11-10       Impact factor: 12.701

7.  Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma.

Authors:  Eleni M Rettig; C Conover Talbot; Mark Sausen; Sian Jones; Justin A Bishop; Laura D Wood; Collin Tokheim; Noushin Niknafs; Rachel Karchin; Elana J Fertig; Sarah J Wheelan; Luigi Marchionni; Michael Considine; Shizhang Ling; Carole Fakhry; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Patrick K Ha; Nishant Agrawal
Journal:  Cancer Prev Res (Phila)       Date:  2016-02-09

Review 8.  Mechanisms of Perineural Invasion.

Authors:  Richard L Bakst; Richard J Wong
Journal:  J Neurol Surg B Skull Base       Date:  2016-03-10

9.  Changes in gene expression in small bowel neuroendocrine tumors associated with progression to metastases.

Authors:  Kendall J Keck; Patrick Breheny; Terry A Braun; Benjamin Darbro; Guiying Li; Joseph S Dillon; Andrew M Bellizzi; Thomas M O'Dorisio; James R Howe
Journal:  Surgery       Date:  2017-11-16       Impact factor: 3.982

Review 10.  Slit/Robo pathway: a promising therapeutic target for cancer.

Authors:  Rishi K Gara; Sonam Kumari; Aditya Ganju; Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Drug Discov Today       Date:  2014-09-20       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.